NorthCoast Asset Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$2.18M Sell
3,505
-1,006
-22% -$676K 0.08% 170
2021
Q2
$2.85M Buy
4,511
+29
+0.6% +$16K 0.1% 151
2021
Q1
$2.19M Buy
4,482
+22
+0.5% +$11K 0.09% 157
2020
Q4
$2.23M Sell
4,460
-946
-17% -$423K 0.1% 131
2020
Q3
$2.13M Sell
5,406
-2,920
-35% -$1.08M 0.11% 119
2020
Q2
$2.75M Sell
8,326
-15,977
-66% -$4.63M 0.16% 96
2020
Q1
$5.89M Buy
24,303
+1,020
+4% +$266K 0.38% 62
2019
Q4
$6.08M Buy
+23,283
New +$6.14M 0.38% 54
2017
Q1
Sell
-14,492
Closed -$1.7M 191
2016
Q4
$1.7M Sell
14,492
-1,249
-8% -$143K 0.17% 83
2016
Q3
$1.77M Buy
+15,741
New +$1.66M 0.14% 90

Other funds holding IDXX

NorthCoast Asset Management's IDXX Position: Q3 2021 in Review

NorthCoast Asset Management reduced its Idexx Laboratories (IDXX) stake by 22% in Q3 2021, selling an estimated $676K and leaving 3,505 shares worth $2.18M. The position accounts for 0.08% of the portfolio, ranked #170.

NorthCoast Asset Management first reported a position in IDXX in Q3 2016 and has held it in 10 quarters since. The position peaked at $6.08M in Q4 2019. 1,059 funds tracked by Wall St. Rank hold IDXX as of Q3 2021.

  • NorthCoast Asset Management held 3,505 shares of Idexx Laboratories worth $2.18M as of Q3 2021.
  • NorthCoast Asset Management sold 1,006 Idexx Laboratories shares in Q3 2021, an estimated $676K.
  • Idexx Laboratories made up 0.08% of NorthCoast Asset Management's portfolio in Q3 2021, its #170 holding.
  • NorthCoast Asset Management first reported a position in Idexx Laboratories in Q3 2016 and has held it in 10 quarters since.
  • NorthCoast Asset Management's Idexx Laboratories position peaked at $6.08M in Q4 2019.
  • 1,059 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2021.

Based on NorthCoast Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.